Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
9.20
+0.31 (3.49%)
May 5, 2026, 12:47 PM EDT - Market open
Nuvectis Pharma Market Cap
Nuvectis Pharma has a market cap or net worth of $254.55 million as of May 5, 2026. Its market cap has increased by 22.75% in one year.
Market Cap
254.55M
Enterprise Value
224.30M
1-Year Change
22.75%
Ranking
Category
Stock Price
$9.20
Market Cap Chart
Since the IPO on February 4, 2022, Nuvectis Pharma's market cap has increased from $58.01M to $254.55M, an increase of 338.83%. That is a compound annual growth rate of 41.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 4, 2026 | 235.51M | 21.78% |
| Dec 31, 2025 | 193.39M | 85.02% |
| Dec 31, 2024 | 104.53M | -27.67% |
| Dec 29, 2023 | 144.50M | 31.58% |
| Dec 30, 2022 | 109.82M | 89.32% |
| Feb 4, 2022 | 58.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arcturus Therapeutics Holdings | 243.59M |
| Polaryx Therapeutics | 242.40M |
| Adagene | 241.83M |
| Orchestra BioMed Holdings | 235.25M |
| Achieve Life Sciences | 233.72M |
| Milestone Pharmaceuticals | 232.42M |
| Keros Therapeutics | 231.72M |
| Voyager Therapeutics | 231.25M |